Details for New Drug Application (NDA): 211055
✉ Email this page to a colleague
The generic ingredient in CARBIDOPA is carbidopa; entacapone; levodopa. There are eighteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the carbidopa; entacapone; levodopa profile page.
Summary for 211055
Tradename: | CARBIDOPA |
Applicant: | Aurobindo Pharma |
Ingredient: | carbidopa |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 211055
Suppliers and Packaging for NDA: 211055
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CARBIDOPA | carbidopa | TABLET;ORAL | 211055 | ANDA | NorthStar Rx LLC | 16714-067 | 16714-067-01 | 100 TABLET in 1 BOTTLE (16714-067-01) |
CARBIDOPA | carbidopa | TABLET;ORAL | 211055 | ANDA | Aurobindo Pharma Limited | 59651-146 | 59651-146-01 | 100 TABLET in 1 BOTTLE (59651-146-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Oct 21, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription